| Tretinoin | Approved Investigational Nutraceutical | RAB6A | 5870 |
downregulated | Tretinoin results in decreased expression of RAB6A mRNA | 11q13.4 | |
| Tretinoin | Approved Investigational Nutraceutical | RAB8A | 4218 |
upregulated | Tretinoin results in increased expression of RAB8A mRNA | 19p13.11 | |
| Tretinoin | Approved Investigational Nutraceutical | RABGAP1L | 9910 |
downregulated | Tretinoin results in decreased expression of RABGAP1L mRNA | 1q25.1 | |
| Tretinoin | Approved Investigational Nutraceutical | RABGGTB | 5876 |
downregulated | Tretinoin results in decreased expression of RABGGTB mRNA | 1p31.1 | |
| Tretinoin | Approved Investigational Nutraceutical | RAC1 | 5879 |
upregulated | Tretinoin results in increased expression of RAC1 mRNA | 7p22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | RAC2 | 5880 |
upregulated | Tretinoin results in increased expression of RAC2 mRNA | 22q13.1 | |
| Tretinoin | Approved Investigational Nutraceutical | RAC3 | 5881 |
downregulated | Tretinoin results in decreased expression of RAC3 mRNA | 17q25.3 | |
| Tretinoin | Approved Investigational Nutraceutical | RAD50 | 10111 |
downregulated | Tretinoin results in decreased expression of RAD50 mRNA | 5q31.1 | |
| Tretinoin | Approved Investigational Nutraceutical | RAD54B | 25788 |
downregulated | Tretinoin results in decreased expression of RAD54B mRNA | 8q22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | RAI14 | 26064 |
downregulated | Tretinoin results in decreased expression of RAI14 mRNA | 5p13.2 | |
| Tretinoin | Approved Investigational Nutraceutical | RAI14 | 26064 |
upregulated | Tretinoin results in increased expression of RAI14 mRNA | 5p13.2 | |
| Tretinoin | Approved Investigational Nutraceutical | RAI2 | 10742 |
downregulated | Tretinoin results in decreased expression of RAI2 mRNA | Xp22.13 | |
| Tretinoin | Approved Investigational Nutraceutical | RAI2 | 10742 |
upregulated | Tretinoin results in increased expression of RAI2 mRNA | Xp22.13 | |
| Tretinoin | Approved Investigational Nutraceutical | RANBP1 | 5902 |
downregulated | Tretinoin results in decreased expression of RANBP1 mRNA | 22q11.21 | |
| Tretinoin | Approved Investigational Nutraceutical | RANBP9 | 10048 |
upregulated | Tretinoin results in increased expression of RANBP9 mRNA | 6p23 | |
| Tretinoin | Approved Investigational Nutraceutical | RAP2A | 5911 |
downregulated | Tretinoin results in decreased expression of RAP2A mRNA | 13q32.1 | |
| Tretinoin | Approved Investigational Nutraceutical | RAP2B | 5912 |
downregulated | Tretinoin results in decreased expression of RAP2B mRNA | 3q25.2 | |
| Tretinoin | Approved Investigational Nutraceutical | RAP2C-AS1 | 101928578 |
upregulated | Tretinoin results in increased expression of RAP2C-AS1 mRNA | Xq26.2 | |
| Tretinoin | Approved Investigational Nutraceutical | RAPGEF4 | 11069 |
upregulated | Tretinoin results in increased expression of RAPGEF4 mRNA | 2q31.1 | |
| Tretinoin | Approved Investigational Nutraceutical | RARA | 5914 |
upregulated | Tretinoin results in increased expression of RARA mRNA | 17q21.2 | |
| Tretinoin | Approved Investigational Nutraceutical | RARA | 5914 |
upregulated | Tretinoin results in increased expression of RARA mRNA alternative form | 17q21.2 | |
| Tretinoin | Approved Investigational Nutraceutical | RARA-AS1 | 101929693 |
upregulated | Tretinoin results in increased expression of RARA-AS1 mRNA | 17q21.2 | |
| Tretinoin | Approved Investigational Nutraceutical | RARB | 5915 |
upregulated | Tretinoin metabolite results in increased expression of RARB mRNA | 3p24.2 | |
| Tretinoin | Approved Investigational Nutraceutical | RARB | 5915 |
downregulated | Tretinoin results in decreased expression of RARB mRNA | 3p24.2 | |
| Tretinoin | Approved Investigational Nutraceutical | RARB | 5915 |
upregulated | Tretinoin results in increased expression of RARB mRNA | 3p24.2 | |